Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM for Pyrotinib-Associated Diarrhea
NCT04988165Phase 2Unknown
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Oct 2021
- Primary completion
- Oct 2022
- Modality
- HMF (Herbal Medicine Formulation)
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bazhengsan in diarrhea, sponsored by Tianjin Medical University Cancer Institute and Hospital. Primary endpoint: Incidence of grade 3-4 diarrhea at 21 days. Status: unknown.
02
Drugs
bazhengsan
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT04988165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04988165.